“I’m struggling to walk,” I’d plead. “To stand. At times, I can barely sit upright, let alone exercise.” But my words were ...

New research helps explain why a subset of patients with relapsing/remitting multiple sclerosis (MS) experience long-term heart rate slowing after taking fingolimod. Various therapies have ...

They say the breakthrough could hasten treatment for thousands of patients diagnosed with multiple sclerosis, or MS, every ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...

Relapsing-remitting multiple sclerosis is an unpredictable disease marked by relapses and remissions, but there are options ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...